Company

Newsroom.

Our press releases provide you with detailed information about Ottobock's products, social responsibility and global presence. Learn about the latest technologies and current highlights in the medical technology sector. As a company that conducts research, we feature numerous interesting topics.

Press releases.

    Image Ottobock Logo Rooftop Headquarter Duderstadt
    Wednesday, 13 May 2026

    Ottobock continues strategic expansion of its Patient Care network with acquisition

    The international listed MedTech company is acquiring the Patient Care business of Blatchford Ltd. UK in Norway
    The international listed MedTech company is acquiring the Patient Care business of Blatchford Ltd. UK in Norway
    After a motorcycle accident, the C-Brace C-Brace Interim paves the way back to a more self-determined life for Peggy. Today she can stand back on the race track and cheer on her friends.
    Monday, 11 May 2026

    Ottobock will be presenting innovative prosthetics and orthotics solutions at OTWorld 2026.

    Product premieres of michelangelo, iconiq and the C Brace Interim address new target groups, broaden the portfolio and contribute to the sector’s future through digitalisation.
    Product premieres of michelangelo, iconiq and the C Brace Interim address new target groups, broaden the portfolio and contribute to the sector’s future through digitalisation.
    Image Ottobock Logo Rooftop Headquarter Duderstadt
    Tuesday, 6 May 2026

    Ottobock continues growth trajectory with significant margin increase.

    • Core revenue increases to € 378.4 million with organic core growth of 5.1 percent • Underlying core EBITDA grows by 11.8 percent to € 84.3 million; underlying core EBITDA margin reaches 22.3 percent • Underlying net income increases by 13.1 percent to € 22.6 million • Guidance 2026 confirmed
    • Core revenue increases to € 378.4 million with organic core growth of 5.1 percent • Underlying core EBITDA grows by 11.8 percent to € 84.3 million; underlying core EBITDA margin reaches 22.3 percent • Underlying net income increases by 13.1 percent to € 22.6 million • Guidance 2026 confirmed
    5243343 Kenevo
    Monday, 4 May 2026

    More Than Mobility: Experts Highlight the Value of Microprocessor-Controlled Knees.

    Online Symposium Highlights Clinical Evidence and Health Economic Findings on MPKs.
    Online Symposium Highlights Clinical Evidence and Health Economic Findings on MPKs.
    Image Ottobock Logo Rooftop Headquarter Duderstadt
    Thursday, 23 April 2026

    World Intellectual Property Day: Ottobock builds on its leadership in innovation.

    With 2,110 patents, 22 first filings and 639 patent families, Ottobock is the leader in prosthetics, neuro-orthotics and exoskeletons.
    With 2,110 patents, 22 first filings and 639 patent families, Ottobock is the leader in prosthetics, neuro-orthotics and exoskeletons.

5 results out of 310